Kmart to Settle FCA Violation Allegations for $32.2 Million

Drug Industry Daily
A A
Kmart agreed to pay a $32.3 million settlement over charges that its in-store pharmacies failed to report discounted drug prices to federal programs and, therefore, were reimbursed at inflated prices.

To View This Article:

Login

Subscribe To Drug Industry Daily